ID: ALA4743456

Max Phase: Preclinical

Molecular Formula: C6H11NO

Molecular Weight: 113.16

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CN1CC=C[C@H](O)C1

Standard InChI:  InChI=1S/C6H11NO/c1-7-4-2-3-6(8)5-7/h2-3,6,8H,4-5H2,1H3/t6-/m0/s1

Standard InChI Key:  GLDHZKQYHDFALD-LURJTMIESA-N

Associated Targets(non-human)

Choline trimethylamine-lyase 35 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 113.16Molecular Weight (Monoisotopic): 113.0841AlogP: -0.15#Rotatable Bonds: 0
Polar Surface Area: 23.47Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.66CX LogP: -0.08CX LogD: -1.36
Aromatic Rings: 0Heavy Atoms: 8QED Weighted: 0.44Np Likeness Score: 1.62

References

1. Gabr, Moustafa T., Machalz, David, Pach, Szymon, Wolber, Gerhard.  (2020)  A benzoxazole derivative as an inhibitor of anaerobic choline metabolism by human gut microbiota,  11  (12.0): [PMID:34095847] [10.1039/d0md00218f]
2. Bollenbach M,Ortega M,Orman M,Drennan CL,Balskus EP.  (2020)  Discovery of a Cyclic Choline Analog That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria.,  11  (10): [PMID:33062182] [10.1021/acsmedchemlett.0c00005]

Source